Alterity Therapeutics Limited

ASX (AUD): Alterity Therapeutics Limited (ATH)

Last Price

0.015

Today's Change

+0.002 (15.38%)

Day's Change

0.012 - 0.015

Trading Volume

45,449,184

Overview

Market Cap

136 Million

Shares Outstanding

9 Billion

Avg Volume

13,212,527

Avg Price (50 Days)

0.01

Avg Price (200 Days)

0.01

PE Ratio

-1.50

EPS

-0.01

Earnings Announcement

04-Aug-2025

Previous Close

0.01

Open

0.01

Day's Range

0.012 - 0.015

Year Range

0.002 - 0.019

Trading Volume

45,449,184

Price Change Highlight

1 Day Change

15.38%

5 Day Change

66.67%

1 Month Change

36.36%

3 Month Change

114.29%

6 Month Change

87.50%

Ytd Change

66.67%

1 Year Change

150.00%

3 Year Change

-6.25%

5 Year Change

-58.33%

10 Year Change

-90.91%

Max Change

-97.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment